Search hospitals > Kentucky > Lexington
Central Kentucky Research Associates, Inc.
Claim this profileLexington, Kentucky 40509
Global Leader in Flu
Conducts research for COVID-19
Conducts research for Tobacco Use
Conducts research for Diabetes
Conducts research for Coronavirus
128 reported clinical trials
3 medical researchers
Summary
Central Kentucky Research Associates, Inc. is a medical facility located in Lexington, Kentucky. This center is recognized for care of Flu, COVID-19, Tobacco Use, Diabetes, Coronavirus and other specialties. Central Kentucky Research Associates, Inc. is involved with conducting 128 clinical trials across 112 conditions. There are 3 research doctors associated with this hospital, such as Mark Adams, Richard M Glover, MD, and Richard M. Glover II.Area of expertise
1Flu
Global Leaderestrogen
ER
2COVID-19
Top PIs
Mark AdamsAlliance for Multispecialty Research, LLC3 years of reported clinical research
Studies Tobacco Use
Studies Migraine
18 reported clinical trials
34 drugs studied
Richard M Glover, MDHeartland Research Associates1 year of reported clinical research
Studies Non-alcoholic Fatty Liver Disease
Studies Fatty Liver Disease
2 reported clinical trials
2 drugs studied
Richard M. Glover IIAlliance for Multispecialty Research, LLC1 year of reported clinical research
Studies Obesity
Studies Diabetes
1 reported clinical trial
2 drugs studied
Clinical Trials running at Central Kentucky Research Associates, Inc.
Obesity
Cardiovascular Disease
Gout
Type 2 Diabetes
COVID-19
Coronavirus
Diabetes
Flu
Migraine
Tobacco Use
Orforglipron
for Type 2 Diabetes and Obesity
The main purpose of this study is to determine safety and efficacy of orforglipron compared with insulin glargine in participants with type 2 diabetes and obesity or overweight at increased cardiovascular risk. The study will last approximately 2 years may include up to 27 visits.
Recruiting2 awards Phase 3
Retatrutide
for Obesity
The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications or prevent the worsening of kidney function. The trial will enroll adults with body mass index 27 kg/m^2 or higher and Atherosclerotic Cardiovascular Disease and/or chronic kidney disease. The study will last for about 5 years. Participants will have up to 27 clinic visits with the study doctor.
Recruiting1 award Phase 32 criteria
BI 456906
for Diabetes and Obesity
This study is open to adults who are at least 18 years old and have a body mass index of 27 kg/m² or more. People can take part if they have type 2 diabetes and if they are currently being treated only with diet and exercise or with specific diabetes medications. Only people who have previously not managed to lose weight by changing their diet can participate. The purpose of this study is to find out whether a medicine called survodutide (BI 456906) helps people living with overweight or obesity who also have diabetes to lose weight. Participants are divided into 3 groups by chance, like drawing names from a hat. 2 groups get different doses of survodutide and 1 group gets placebo. Placebo looks like survodutide but does not contain any medicine. Every participant has a 2 in 3 chance of getting survodutide. Participants inject survodutide or placebo under their skin once a week for about one and a half years. In addition to the study medicine, all participants receive counselling to make changes to their diet and to exercise regularly. Participants are in the study for about 1 year and 7 months. During this time, it is planned that participants visit the study site up to 14 times and receive 6 phone calls by the site staff. The doctors check participants' health and take note of any unwanted effects. The study staff also regularly measure participants' body weight. The results are compared between the groups to see whether the treatment works.
Recruiting1 award Phase 37 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Central Kentucky Research Associates, Inc.?
Central Kentucky Research Associates, Inc. is a medical facility located in Lexington, Kentucky. This center is recognized for care of Flu, COVID-19, Tobacco Use, Diabetes, Coronavirus and other specialties. Central Kentucky Research Associates, Inc. is involved with conducting 128 clinical trials across 112 conditions. There are 3 research doctors associated with this hospital, such as Mark Adams, Richard M Glover, MD, and Richard M. Glover II.